Meghmani Organics Ltd - 543331 - Audio Recording Of Earning Call Of Q3/9M FY2023 Financial Results
Audio recording of Earning Call of Q3/9M FY2023 Financial Results23-01-2023
23-01-2023
Results Earnings Call for Q3FY23 of Meghmani Organics
Conference Call with Meghmani Organics Management and Analysts on Q3FY23 Performance and Outlook. Listen to the full earnings transcript.23-01-2023
Meghmani Organics Ltd - 543331 - Announcement under Regulation 30 (LODR)-Investor Presentation
Revised Investor Presentation on Financial Results for Q3/9M FY202323-01-2023
Q3FY23 Quarterly Result Announced for Meghmani Organics Ltd.
Agrochemicals firm Meghmani Organics announced Q3FY23 results: Q3FY23: The company could achieve a revenue of Rs 554 crore and Rs 1,992 crore for 9MFY23 EBITDA margins achieved 11% for Q3 and 14% for 9MFY23. The dip in performance in pigments was offset by agrochemicals. Agrochemicals: constitutes 75% of the overall company’s revenue. During this quarter, the company was able to maintain EBITDA margins of 19.2% (against 17.5% in Q3FY22) despite adverse global macro challenges. The company is well positioned to benefit from ‘China plus one’ strategy of global players coupled with capex plans eyeing on new molecules in agrochemicals. Pigments: constitute 25% of the overall company’s revenue. Currently pigment is witnessing slow export demand and contraction in prices due to challenging global macro environment. During the quarter pigment performance has been adversely impacted due to liquidation of high-cost inventory. We expect the recovery in the demand in the pigment division in the next few quarters. Finance Cost: MTM gain of Rs 73 crore on receivables has been shown as other income. MTM loss on foreign currency borrowing Rs 38 crore has been accounted as finance cost. Out of Rs 38 crore MTM loss, Rs 35 crore is unrealised MTM loss. During the Q3FY23, there is net foreign currency loss of Rs 19 crore while for 9M period there is a net foreign currency gain of Rs 35 crore. Borrowing cost net of foreign currency impact is Rs 5.4 crore for Q3 and Rs 11.7 crore for 9MFY23 Commenting on this quarter’s performance, Mr. Ankit Patel, CEO said “the commercial production of the agrochemicals new Multi Product Plant was commenced in Q3 FY23 and plant is getting stabilised. It will add meaningful contribution from the next financial year. During the quarter, the company has entered into long term supply contract for 5 years with reputed Multinational Customer for its Agro Products. Total value of the contract is approximately Rs. 800 Cr. Also, the company shall foray into Nano Urea (Liquid) fertilizer through our wholly owned subsidiary Meghmani Crop Nutrition Ltd (MCNL) for which the company will incur a capex of Rs 150 crores for setting up the plant in Gujarat with annual capacity of 5 crore bottles (~500 ml) per year. The plant will commence commercial production from Q4FY24. MNCL aims to achieve a topline of INR 1,000 crores on an annualized basis. One of the essential developments is that on the pigment side, the Phase 1 of the Titanium Dioxide plant with 16,500 tons capacity was commissioned on 18th January 2023. The team is working towards stabilizing the plant and the Phase 2 capex plan of doubling TiO2 capacity to 33,000 tons p.a. along with captive power plant is expected to be completed in Q3 FY24 at capex of Rs 375 crore”. Result PDF23-01-2023
Meghmani Organics Ltd - 543331 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on commissioning of Titanium Dioxide (TiO2) plant23-01-2023
Meghmani Organics Ltd - 543331 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Press Release on Q3/9M FY2023 Financial Results23-01-2023
Meghmani Organics Ltd - 543331 - Announcement under Regulation 30 (LODR)-Investor Presentation
Investor Presentation on Financial Results for Q3/9M FY202321-01-2023
Meghmani Organics Ltd - 543331 - Outcome Of The Board Meeting Held On January 21, 2023 And Submission Of Un-Audited Financial Results (Standalone And Consolidated) For The Third Quarter And Nine Months Ended On December 31, 2022
Outcome of the Board Meeting held on January 21, 2023 and submission of un-audited Financial Results (Standalone and Consolidated) for the Third quarter and Nine months ended on December 31, 2022 pursuant to regulation 33 of the SEBl (Listing Obligations and Disclosure Requirements), Regulations, 201521-01-2023
Meghmani Organics Ltd - 543331 - Board Meeting Outcome for Outcome Of The Board Meeting Held On January 21, 2023 And Submission Of Un-Audited Financial Results (Standalone And Consolidated) For The Third Quarter And Nine Months Ended On December 31, 2022
Outcome of the Board Meeting held on January 21, 2023 and submission of un-audited Financial Results (Standalone and Consolidated) for the Third quarter and Nine months ended on December 31, 2022 pursuant to regulation 33 of the SEBl (Listing Obligations and Disclosure Requirements), Regulations, 201521-01-2023
Meghmani Organics Ltd - 543331 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Schedule of Earning Conference call to discuss Q3 & 9MFY23 Financial Results16-01-2023